Envista Announces Participation in Jefferies London Healthcare Conference
Envista Holdings Corporation (NYSE: NVST) announced its participation in the Jefferies London Healthcare Conference on November 17, 2022, from 9:45 - 10:15 AM GMT.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Envista Holdings Corporation (NYSE: NVST) announced its participation in the Jefferies London Healthcare Conference on November 17, 2022, from 9:45 - 10:15 AM GMT. Investors can access audio recordings of the event via the Investor Relations section on Envista's website. Envista, a leading global dental products company with over 30 renowned brands, focuses on enhancing patient care through innovative solutions and services.
Positive
- Participation in a high-profile healthcare conference enhances visibility.
- Access to audio recordings offers investment insights for stakeholders.
Negative
- None.
Details
News Market Reaction – NVST
The recorded move for NVST in the trading session of this news was +3.51%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BREA, Calif., Oct. 31, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Jefferies London Healthcare Conference on Thursday, November 17, 2022, from 9:45 – 10:15 AM GMT.
Investors will be able to access any applicable audio recordings through Envista's Investor Relations website under the subheading Events and Presentations.
Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, DEXIS, Ormco, and Kerr united by a shared purpose: to partner with professionals to improve lives. Envista helps its customers deliver the best possible patient care through industry-leading dental consumables, solutions, technology, and services. Our comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a broad range of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the aesthetics of the human smile. With a foundation comprised of the proven Envista Business System (EBS) methodology, an experienced leadership team, and a strong culture grounded in continuous improvement, commitment to innovation, and deep customer focus, Envista is well equipped to meet the end-to-end needs of dental professionals worldwide. Envista is one of the largest global dental products companies, with significant market positions in some of the most attractive segments of the dental products industry. For more information, please visit www.envistaco.com.
For Further Information
Stephen Keller
Vice President, Investor Relations
Envista Holdings Corporation
200 S. Kraemer Blvd., Building E
Brea, CA 92821
Telephone: (714) 817-7000
Fax: (714) 817-5450
View original content to download multimedia:https://www.prnewswire.com/news-releases/envista-announces-participation-in-jefferies-london-healthcare-conference-301662366.html
SOURCE Envista Holdings Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.